Browsing Tag

CareDxs

Landmark ADMIRAL Study Publication with CareDx’s AlloSure Kidney is the First…

Eli Pacheco Jan 12, 2022 0

ADMIRAL Study Shows AlloSure Detects Clinical and Subclinical ABMR and TCMR, and Predicts Long-Term Outcomes for Kidney Transplant Patients AlloSure Showed 62% Improvement Over Standard of…

Health

NIH Study Shows Using CareDx’s AlloSure Lung for Transplant Surveillance is More…

Eli Pacheco Jan 7, 2022 0

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of…

Health

University of Alabama Integrates CareDx’s TxAccess for Connection to Over 500…

Eli Pacheco Nov 4, 2021 0

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and…